AwesomeCapital
Search This Blog
Wednesday, February 26, 2025
'Enveric Non-Hallucinogenic Psychedelic Compounds Show Promise to Treat Addiction, ADHD'
Enveric receives its first patent for psychedelic-derived mescaline compounds.
Non-hallucinogenic drugs aim to help with addiction, ADHD and anxiety.
https://www.benzinga.com/general/health-care/25/02/43956672/exclusive-non-hallucinogenic-psychedelic-compounds-show-promise-for-treating-addiction-and-adhd
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.